2/28/2026

HealthKey

AI-powered Patient Identification service for Clinical Trial Sites that matches trial eligibility criteria with patient EHR data to accelerate clinical trial enrollment

Disclaimer: This report is based on publicly available information and AI analysis. It does not constitute investment advice. Always conduct your own due diligence before making investment decisions.
54

HealthKey

AI-powered Patient Identification service for Clinical Trial Sites that matches trial eligibility criteria with patient EHR data to accelerate clinical trial enrollment

38
Risk
Execution, regulatory & market risk
42
Team
Experience, domain fit & gaps
72
Market
TAM size, growth rate & timing
45
Traction
Evidence of demand & momentum

Executive Summary

HealthKey is a YC W25 pre-seed startup building AI-powered patient identification for clinical trial sites — a real, growing market where 80%+ of trials fail to hit enrollment targets and multiple data sources confirm a $187M direct TAM growing at 13.5% CAGR. The core product claim checks out: the website is live, EHR integration is described clearly, and YC acceptance is confirmed. However, this is a solo-founder company with ~10 employees, no disclosed co-founder or CTO, no public revenue metrics, and no confirmed clinical or regulatory expertise on the team — in a space that demands HIPAA compliance, FDA 21 CFR Part 11 awareness, and deep EHR integration work. The single biggest risk is not the market or the product concept; it's that a technically demanding, heavily regulated product is being built by one identified founder without the domain depth or team breadth that this category typically requires to win.

Run your own diligence

Upload a pitch deck or paste any company URL to get a full AI-powered due diligence report in under 2 minutes.

Get started free →

Free plan available · No credit card required